Xeris Pharmaceuticals | XERS - Net Income

Stock Price
5.40
Daily Change
-0.21 -3.74%
Monthly
-19.76%
Yearly
-2.00%
Q1 Forecast
5.30

Xeris Pharmaceuticals reported $621K in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Celltrion KRW 331.35B 270.18B Sep/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 5.83B 1.06B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -226K 121K Dec/2025
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Ovoca Bio EUR -5.65M 3.28M Jun/2022
Pacira USD 1.64M 3.8M Dec/2025
Perrigo USD -1.42B 1.43B Dec/2025
Pharma Mar EUR 59.66M 63.76M Dec/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
Sartorius EUR 43.8M 11.3M Sep/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Tilray USD -44.93M 44.61M Sep/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025